Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Influences on plasminogen activator inhibitor-2 polymorphism-associated recurrent cardiovascular disease risk in patients with high HDL cholesterol and inflammation.

Atherosclerosis - 1 Jul 2016

Corsetti James P, Salzman Peter, Ryan Dan, Moss Arthur J, Zareba Wojciech, Sparks Charles E

Abstract excerpt

BACKGROUND AND AIMS: Evidence continues to accumulate that athero-protective effects of high-density lipoprotein (HDL) depend to some degree on effective HDL functionality and that such functionality can become degraded in the setting of chronic inflammation. To investigate this issue, we have studied a group of post-myocardial infarction patients with high levels of C-reactive protein as an indicator of chronic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to C-Reactive Protein
Share to Cholesterol, HDL

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lipoproteins, HDL

Share to Models, Theoretical

Share to Multivariate Analysis

Share to Myocardial Infarction

Share to Recurrence

Share to Tissue Plasminogen Activator

Source

Identifiers

PMID: 27174532
DOI: 10.1016/j.atherosclerosis.2016.04.017

Genes

SERPINB2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Influences on plasminogen activator inhibitor-2 polymorphism-associated recurrent cardiovascular disease risk in patients with high HDL cholesterol and inflammation.PMID 27174532Read ↗

Plasminogen activator inhibitor-2 polymorphism associates with recurrent coronary event risk in patients with high HDL and C-reactive protein levels.Semantic proximity Read ↗

Circulating causal protein networks linked to future risk of myocardial infarctionSemantic proximity Read ↗

Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology.Semantic proximity Read ↗

Evaluation of plasma biomarkers for causal association with peripheral artery diseaseSemantic proximity Read ↗

Evaluation of Plasma Biomarkers for Causal Association With Peripheral Artery Disease.Semantic proximity Read ↗

Interaction between a genetic variant of the platelet fibrinogen receptor and fibrinogen levels in determining the risk of cardiovascular events.Semantic proximity Read ↗

Multiomics Analysis Coupled with Text Mining Identify Novel Biomarker Candidates for Recurrent Cardiovascular Events.Semantic proximity Read ↗

TNFR Pathway-Related Proteins and Recurrent Coronary Artery Disease EventsSemantic proximity Read ↗

MicroRNAs within the continuum of postgenomics biomarker discovery.Semantic proximity Read ↗

Clinical and genetic factors associated with lipoprotein-associated phospholipase A2 in the Framingham Heart Study.Semantic proximity Read ↗

Polymorphisms of prostaglandin-endoperoxide synthase 2 gene, and prostaglandin-E receptor 2 gene, C-reactive protein concentrations and risk of atherothrombosis: a nested case-control approach.Semantic proximity Read ↗

Complex adaptive system models and the genetic analysis of plasma HDL-cholesterol concentration.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.